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In membranes of myeloid differentiated HL 60 cells, the chemotactic peptide FMLP stimulates phospho- 
lipase C via a pertussis toxin-sensitive G protein. FMLP markedly stimulates the cholera toxin-dependent 
ADP-ribosylation of a 40 kDa protein in these membranes. This effect of FMLP is inhibited by GTP and 
GTP[S], and is almost completely abolished in membranes of pertussis toxin-pretreated HL 60 cells. Treat- 
ment of HL 60 membranes with cholera toxin and NAD markedly inhibits FMLP-stimulated high affinity 
GTPase. These results uggest hat a 40 kDa G protein sensitive to both pertussis and cholera toxin func- 
tionally interacts with the formyl peptide receptor of HL 60 cells and, thus, very likely is the G protein 
that stimulates phospholipase C in this system. 
G protein; ADP-ribosylation; Cholera toxin: Formyl peptide; Neutrophil: Phospholipase C 
1. INTRODUCTION 
Recent evidence suggests that guanine 
nucleotide-binding proteins are involved in cou- 
pling a variety of calcium mobilizing receptors to 
phospholipase C [1]. In certain cell types, e.g. 
human leukemia (HL 60) cells, neutrophils, mast 
cells and fibroblasts, the relevant G protein is func- 
tionally inactivated by pertussis toxin. In these 
systems, pertussis toxin ADP-ribosylates a 40 kDa 
membrane protein that is structurally different 
from described pertussis toxin substrates [2]. 
While this protein has been suggested to be the G 
protein that stimulates phospholipase C, direct 
evidence for coupling of the protein to 
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phospholipase C or to calcium mobilizing recep- 
tors, has so far not been presented. 
Membranes prepared from myeloid differen- 
tiated HL 60 cells contain high numbers of formyl 
peptide receptors which are coupled to stimulation 
of phospholipase C [3] and do not interact with the 
adenylate cyclase system [4,5]. Therefore, this 
sytem provides an excellent model to study struc- 
ture and function of G proteins involved in cou- 
pling receptors to phospholipase C. In the present 
study we used a novel approach, i.e. receptor- 
mediated ADP-ribosylation of a G protein, to 
demonstrate, without relying on reconstitution 
techniques, that a 40 kDa G protein is functionally 
coupled to the formyl peptide receptor in native 
HL 60 membranes. Our results strongly suggest 
that this protein is the G protein that couples for- 
myl peptide receptors to phospholipase C in HL 60 
membranes. 
Abbreviations: G protein, guanine nucleotide-binding 
protein; FMLP, N- formyl-methionyl-leucyl-phenyl- 
alanine; GTP[S], guanosine-5'-O-(3-thiotriphosphate); 
GppNHp, guanylyl-imidodiphosphate 
2. MATERIALS AND METHODS 
HL 60 cells were grown in suspension culture 
and induced to differentiate into mature myeloid 
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forms by cultivation in the presence of 1.25% (v/v) 
dimethyl sulfoxide (DMSO) for 5 days [6]. Mem- 
branes were prepared as described [2] except that 
centrifugation through Percoll gradients was 
omitted. 
For [32p]ADP-ribosylation of membrane pro- 
teins, cholera toxin (2 mg/ml,  Sigma) was ac- 
tivated by dilution with an equal volume of 40 mM 
dithiothreitol and incubated for 10 min at 30°C. 
Membranes (50-100#g protein) were incubated 
for 60 rain at 37°C in a volume of 50/A containing 
100 mM potassium phosphate buffer, pH 7.5, 
2.5 mM MgClz, 1 mM ATP, 10 mM thymidine, 
10 mM arginine, 100/~g/ml activated cholera tox- 
in, 1/~M [32p]NAD (20/~Ci/nmol), and guanine 
nucleotides and FMLP at concentrations indicated 
in the figure legends. 
For treatment of membrane proteins with 
cholera toxin and non-radioactive NAD, mem- 
branes (1 mg/ml) were incubated for the times in- 
dicated in a buffer containing 50 mM 
triethanolamine/HC1, pH 7.4, 2 mM ATP, 
10 mM NAD, 2.5 mM MgC12, and 100/~g/ml of 
activated cholera toxin or an equal volume of the 
carrier solution. At the end of the incubation 
period, the membranes were washed at 4°C with 
10 mM triethanolamine/HCl, pH 7.4, and directly 
used for determination of GTPase activities. 
Hydrolysis of [y-32p]GTP (0.1/~Ci per tube) was 
determined in a reaction mixture (100/A) contain- 
ing 5-10/~g membrane protein, 50 mM triethanol- 
amine/HCl,  pH 7.4, 1 mM dithiothreitol, 0.1 mM 
EGTA, 2 mM MgCI2, 100mM NaC1, 0.1/~M 
GTP, 0.1 mM ATP, 5 mM creatine phosphate 
(sodium salt), 0.4 mg/ml creatine kinase, and 
0.2% (w/v) bovine serum albumin. Reactions were 
performed for 10 min at 25°C in the absence or 
presence of 1/~M FMLP. Reactions were ter- 
minated and high affinity GTPase activity was 
determined as described [7]. 
[y-32p]GTP and [32p]NAD were synthesized as 
described [8,9]. SDS-polyacrylamide gel elec- 
trophoresis and autoradiography were performed 
as described in [2]. Protein was determined ac- 
cording to Bradford [10] using bovine IgG as a 
standard. 
3. RESULTS AND DISCUSSION 
When HL 60 membranes were treated with 
cholera toxin and [32p]NAD, addition of the 
chemotactic peptide FMLP to the reaction mixture 
markedly stimulated the ADP-ribosylation of a 
40 kDa membrane protein (fig.l). In contrast, 
there was no effect of FMLP on the cholera toxin- 
dependent ADP-ribosylation of the 43 kDa 
substrate which presumably corresponds to the ~- 
subunit of the stimulatory G protein of adenylate 
cyclase, Gs. The effect of FMLP was 
concentration-dependent with half-maximal and 
maximal effects at approx. 0.1 and 1/~M, respec- 
tively. FMLP had no effect on the labelling of pro- 
teins in the absence of cholera toxin (not shown). 
Fig.2 shows the effects of guanine nucleotides 
on the cholera toxin-dependent ADP-ribosylation 
of the 40 kDa membrane protein. As described 
before [11,12], in the absence of guanine 
nucleotides there was significant ADP-ribosylation 
of the 40 kDa substrate even in the absence of 
FMLP. This basal labelling was reduced or even 
absent in the presence of GTP and the metabolical- 
ly stable GTP-analogs GppNHp and GTP[S]. In 
contrast, only GTP[S] and GTP, but not 
GppNHp,  inhibited the effect of FMLP on label- 
ling of the 40 kDa protein. This inhibition suggests 
that the stimulation of ADP-ribosylation of the 
40 kDa protein by FMLP cannot be attributed to 
the stimulation of FMLP-dependent effector en- 
zymes, e.g. phospholipase C or protein kinase C, 
since these effects of FMLP are enhanced or even 
mimicked by GTP and GTP[S] [13,14]. 
Effects of guanine nucleotides on ADP- 
ribosylation of membrane proteins by bacterial 
toxins do not necessarily imply that the substrate 
itself is a GTP-binding protein. A second G pro- 
tein, also referred to as ADP-ribosylation factor 
(ARF) has recently been shown to be required for 
ADP-ribosylation of Gs by cholera toxin [15]. 
However, binding of GTP[S] or GTP to ARF 
stimulates, rather than inhibits, the ADP- 
ribosylation of Gs [15]. Hence, it appears unlikely 
that GTP[S] and GTP act via a G protein similar 
or identical to ARF. Instead, the findings indicate 
that a complex of the active formyl peptide recep- 
tor with the nucleotide-free 40 kDa protein serves 
as the actual cholera toxin substrate, and that 
binding of both GTP[S] and GTP to the 40 kDa 
substrate inhibits the formation of this complex. 
At first glance, the striking difference between 
the two metabolically stable GTP analogues, 
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Fig.l. Stimulation by FMLP of the cholera toxin- 
dependent ADP-ribosylation of a 40 kDa protein in 
HL 60 membranes. Membranes were incubated with 
cholera toxin, [32p]NAD and the indicated 
concentrations of FMLP. As FMLP is maximally 
effective in supporting the labelling of the 40 kDa 
protein the presence of GppNHp (see fig.2), 100#M 
GppNHp, was included in the reaction mixture. The 
samples were subjected to SDS-polyacrylamide gel 
electrophoresis and autoradiography of the dried gel was 
performed. The 40 kDa cholera toxin substrate 
comigrates on SDS-polyacrylamide g ls with the 40 kDa 
pertussis toxin substrate of HL 60 membranes. The 
43 kDa cholera toxin substrate comigrates with the c~- 
subunits of Gs, which are present in membranes 
prepared from wild type S 49 lymphoma cells, but 
absent from cyc- mutant membranes [29] (not shown). 
GTP[S] and GppNHp, in affecting the FMLP- 
stimulated ADP-ribosylation of the 40 kDa pro- 
tein may appear to be contradictory. However, a 
similar difference has been reported for the cholera 
toxin-dependent ADP-ribosylation of transducin, 
which is also stimulated by an activated receptor, 
i.e. light-activated rhodopsin [16,17]. In this 
system, GppNHp was found to actually stimulate 
the G protein ADP-ribosylation, whereas GTP[S] 
was strongly inhibitory. Thus, the GppNHp-, but 
not the GTP[S]-ligand form, of both transducin 
and the HL 60 substrate appears to be capable of 
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Fig.2. Effect of guanine nucleotides on the cholera 
toxin-dependent ADP-ribosylation of the 40 kDa 
substrate. HL 60 membranes were incubated with 
cholera toxin and [3zP]NAD in the absence (control) and 
presence of 100 #M of the indicated guanine nucleotides 
and in the absence ( - ) or presence (+) of 10 #M FMLP. 
The samples were subjected to SDS-polyacrylamide g l 
electrophoresis and autoradiography of the dried gel was 
performed. Only the 40 kDa region of the 
autoradiogram is shown. 
interacting with activated receptors and subse- 
quently serving as a substrate for the toxin. In fact, 
a similar, fundamental difference between 
GppNHp and GTP[S] in affecting receptor-G pro- 
tein coupling has also been observed for the cou- 
pling of Gs to the/Y-adrenoceptor [18]. 
The ADP-ribosylation of the 40 kDa G protein 
by cholera toxin is functionally correlated with a 
marked inhibition of FMLP-stimulated GTPase 
activity (fig.3). Half-maximal and maximal (80%) 
inhibition was seen after preincubation of the 
membranes with the toxin for 15 and 120 min, 
respectively. This time dependence strongly sug- 
gests that cholera toxin inhibits FMLP-stimulated 
GTP hydrolysis by an enzymatic activity and is 
consistent with an ADP-ribosylation of a G pro- 
tein being the mechanism of action of the toxin. 
The inhibition of FMLP-stimulated GTPase activi- 
ty by cholera toxin cannot be attributed to a toxin- 
induced increase in cAMP formation, since the ad- 
dition of 100#M cAMP and 1 mM of the 
phosphodiesterase inhibitor 3-isobutyl-l-methyl- 
xanthine to the preincubation mixture, to the buf- 
fer used for determination of GTP hydrolysis, or 
both, had no effect on GTP hydrolysis both in the 
absence and presence of FMLP (not shown). 
Cholera toxin-dependent ADP-ribosylation of Gs 
results in an inhibition of the GTPase activity of Gs 
[19]. It appears unlikely, however, that ADP- 
ribosylation of Gs leads to an inhibition of the 
FMLP-dependent GTPase activity, since there is 
no evidence that formyl peptide receptors couple 
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Fig.3. Inhibition by cholera toxin of the FMLP- 
stimulated GTPase activity in HL 60 membranes. HL 60 
membranes were treated with (e) or without (©) 
activated cholera toxin (CT). At the indicated time 
points, membranes were withdrawn and the FMLP- 
stimulated GTPase activity was determined. Given at the 
ordinate is the increase in high affinity GTPase activity 
caused by the addition of 1/~M FMLP, which was about 
2.2-fold at t = 0. The inhibitory effect of cholera toxin 
on FMLP-stimulated GTPase activity is strictly 
dependent on the presence of NAD during the 
preincubation, and is dependent on the concentration f 
the toxin. Half-maximal and maximal effects were seen 
at concentrations of about 5 and 100/~g/ml (not shown). 
to Gs in HL 60 membranes. Similarly unlikely is an 
interaction of formyl peptide receptors with 
transducin, since several polyclonal antisera 
strongly reactive against transducin fail to detect 
any crossreactive material in HL 60 membranes. 
Thus, the results suggest hat a G protein distinct 
from Gs and transducin, most likely the 40 kDa 
substrate, gives rise to the cholera toxin-sensitive 
GTPase activity in response to FMLP. 
There is the distinct possibility that the cholera 
toxin-dependent ADP-ribosylation of the G pro- 
tein coupled to the formyl peptide receptor also in- 
hibits the stimulation of FMLP-dependent effector 
enzymes, including phospholipase C. Inhibition of 
several neutrophil functions has been noticed by 
several investigators [20-24]. Specifically, the in- 
hibition of macrophage chemotaxis by cholera tox- 
in has been reported to be independent of a 
toxin-dependent i crease in cellular cAMP [11]. In 
addition, in at least two other systems, there is a 
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Fig.4. Inhibition by pertussis toxin of the FMLP- 
stimulated ADP-ribosylation of the 40 kDa substrate. 
HL 60 cells were treated for 3 h at 37°C with (lanes 3 
and 4) or without (lanes 1 and 2) pertussis toxin (PT, 
500 ng/ml). Membranes were prepared and treated with 
[32p]NAD and activated cholera toxin in the presence 
(lanes 2 and 4) or absence (lanes 1 and 3) of 10/~M 
FMLP. The samples were subjected to SDS- 
polyacrylamide g l electrophoresis and autoradiography 
of the dried gel was performed. Only the 40 kDa region 
of the autoradiogram is shown. 
marked, cAMP-independent inhibition by cholera 
toxin of phosphoinositide hydrolysis [25,26]. 
ADP-ribosylation of G proteins by pertussis tox- 
in generally leads to a functional uncoupling of the 
modified G protein from the corresponding recep- 
tor. When intact HL 60 cells are treated with per- 
tussis toxin, and membranes were tested for 
ADP-ribosylation of proteins by cholera toxin, 
there was a significant inhibition of basal and an 
almost complete loss of FMLP-stimulated ADP- 
ribosylation of the 40 kDa protein (fig.4). These 
findings strongly suggest that a single 40 kDa pro- 
tein serves as a substrate for both toxins in HL 60 
membranes. The major 40 kDa pertussis toxin 
substrate of neutrophils and HL 60 ceils is struc- 
turally different from all previously described per- 
tussis toxin substrates [2]. Therefore, our data 
suggest that this novel GTP-binding protein, which 
we have named G., is a substrate for cholera toxin 
when bound to the formyl peptide receptor. This 
demonstration of a functional interaction with a 
calcium mobilizing receptor provides strong 
evidence that this G protein is involved in regula- 
tion of phospholipase C in this system. 
It is presently unknown whether a single amino 
acid or two different sites of the 40 kDa substrate 
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are modified by cholera and pertussis toxin. There 
is good evidence, however, that two different 
amino acids, cysteine-346 and arginine-174, are 
ADP-ribosylated by pertussis and cholera toxin, 
respectively, on the c~-subunit of transducin 
[27,28]. As the 40 kDa protein of HL 60 mem- 
branes is very similar to transducin in terms of the 
characteristics and functional consequences of the 
toxin-dependent modifications, the 40 kDa protein 
may be ADP-ribosylated at two distinct sites as 
well. Interestingly, the primary structure derived 
from all cDNA clones coding for signal transduc- 
ing G proteins isolated to date contain an arginine 
in a position that corresponds to arginine-174 of cet 
[29]. Therefore, other G proteins, e.g. the in- 
hibitory G protein of adenylate cyclase (Gi) or Go, 
a G protein of unknown function found in brain, 
may also undergo agonist-stimulated ADP- 
ribosylation by cholera toxin. If true, this would 
provide a powerful tool to determine, within the 
native plasma membrane, which G protein couples 
to a given receptor, e.g. inhibitory receptors of 
adenylate cyclase, or to identify the receptors that 
interact with a specific G protein. 
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